Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodologyGiacomo Pascarella, Alessandro Morabito, Arturo Capasso et al.|PLoS ONE|2019Cited by 16
Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II studyCesare Gridelli, Luigi Manzione, L Brancaccio et al.|Lung Cancer|2000Cited by 7